论文检索
期刊
全部知识仓储预印本开放期刊机构
高级检索

REDH:A database of RNA editome in hematopoietic differentiation and malignancyOACSTPCDMEDLINE

中文摘要

Background:The conversion of adenosine(A)to inosine(I)through deamination is the prevailing form of RNA editing,impacting numerous nuclear and cytoplasmic transcripts across various eukaryotic species.Millions of high-confidence RNA editing sites have been identified and integrated into various RNA databases,providing a convenient platform for the rapid identification of key drivers of cancer and potential therapeutic targets.However,the available database for integration of RNA editing in hematopoietic cells and hematopoietic malignancies is still lacking.Methods:We downloaded RNA sequencing(RNA-seq)data of 29 leukemia patients and 19 healthy donors from National Center for Biotechnology Information(NCBI)Gene Expression Omnibus(GEO)database,and RNA-seq data of 12 mouse hematopoietic cell populations obtained from our previous research were also used.We performed sequence alignment,identified RNA editing sites,and obtained characteristic editing sites related to normal hematopoietic development and abnormal editing sites associated with hematologic diseases.Results:We established a new database,"REDH",represents RNA editome in hematopoietic differentiation and malignancy.REDH is a curated database of associations between RNA editome and hematopoiesis.REDH integrates 30,796 editing sites from 12 murine adult hematopoietic cell populations and systematically characterizes more than 400,000 edited events in malignant hematopoietic samples from 48 cohorts(human).Through the Differentiation,Disease,Enrichment,and knowledge modules,each A-to-I editing site is systematically integrated,including its distribution throughout the genome,its clinical information(human sample),and functional editing sites under physiological and pathological conditions.Furthermore,REDH compares the similarities and differences of editing sites between different hematologic malignancies and healthy control.Conclusions:REDH is accessible at http://www.redhdatabase.com/.This user-friendly database would aid in understanding the mechanisms of RNA editing in hematopoietic differentiation and malignancies.It provides a set of data related to the maintenance of hematopoietic homeostasis and identifying potential therapeutic targets in malignancies.

Jiayue Xu;Jiahuan He;Jiabin Yang;Fengjiao Wang;Yue Huo;Yuehong Guo;Yanmin Si;Yufeng Gao;Fang Wang;Hui Cheng;Tao Cheng;Jia Yu;Xiaoshuang Wang;Yanni Ma;

State Key Laboratory of Common Mechanism Research for Major Diseases,Haihe Laboratory of Cell Ecosystem,Institute of Basic Medical Sciences,Chinese Academy of Medical Sciences,Beijing 100005,ChinaKey Laboratory of RNA and Hematopoietic Regulation,Chinese Academy of Medical Sciences,Beijing 100005,ChinaState Key Laboratory of Common Mechanism Research for Major Diseases,Haihe Laboratory of Cell Ecosystem,Institute of Basic Medical Sciences,Chinese Academy of Medical Sciences,Beijing 100005,China Department of Biochemistry and Molecular Biology,Chinese Academy of Medical Sciences,School of Basic Medicine Peking Union Medical College,Beijing 100005,ChinaState Key Laboratory of Experimental Hematology,National Clinical Research Center for Blood Diseases,Institute of Hematology and Blood Diseases Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Tianjin 300020,ChinaState Key Laboratory of Common Mechanism Research for Major Diseases,Haihe Laboratory of Cell Ecosystem,Institute of Basic Medical Sciences,Chinese Academy of Medical Sciences,Beijing 100005,China Institute of Blood Transfusion,Chinese Academy of Medical Sciences,Chengdu,Sichuan 610052,ChinaDepartment of Biochemistry and Molecular Biology,Chinese Academy of Medical Sciences,School of Basic Medicine Peking Union Medical College,Beijing 100005,China

临床医学

RNA editing;Hematopoietic differentiation;Hematopoietic malignancy;Database management systems

《Chinese Medical Journal》 2024 (003)

P.283-293 / 11

supported by grants from the National Key Research and Development Program of China(Nos.2022YFA1106300,2019YFA0802603,2019YFA0801800,2019YFA0111700,and 2021YFA0805703);the National Natural Science Foundation of China(Nos.92268205,82122005,81970154,81970101,82270192);CAMS Innovation Fund for Medical Sciences(No.2021-I2M-1-019);Haihe Laboratory of Cell Ecosystem Innovation Fund(No.22HHXBSS00027)

10.1097/CM9.0000000000002782

评论

下载量:0
点击量:0